Bull, "Outcomes of submandibular duct re-implantation for sialorrhoea
," Clinical Otolaryngology and Allied Sciences, vol.
Injection of botulinum toxin A in to salivary glands improve sialorrhoea in amyotropic lateral sclerosis.
Clinical study of botulinum toxin- A in the treatment of sialorrhoea in children with cerebral palsy.
(16.) Hockstein NG, Samadi DS, Gendron K, Handler SD, Sialorrhoea: a management Challenge, Am Fam Physician 2004; 69:2628-2634.
Controlling sialorrhoea: a review of available treatment options.
Drooling was assessed based on the classification drafted by Thomas-Stonell and Greenberg (1988).16 Drooling was evaluated since research has demonstrated a significant relationship between sialorrhoea
during sleep and bruxism.
Botulinum toxin in the management of sialorrhoea
: a systematic review.
Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea
, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain).
was not seen, which might have been due to administration of injection atropine as premedication.